New Free Clinical Trials Search Tool for Mesothelioma Launches

• Maja Belamaric
• Featured News
• December 9, 2025

A new, free online search tool dedicated exclusively to mesothelioma clinical trials has launched on mesotheliomahelp.org, offering patients, physicians, and researchers a focused resource to find and share trials specific to mesothelioma and its subtypes. The platform, which is the first of its kind devoted solely to mesothelioma, combines detailed disease-specific filters with geographic search capability and an easy process for clinicians and investigators to submit trials for inclusion.

The tool’s design focuses on two core needs: helping patients and families find relevant trials quickly and giving doctors and researchers a simple way to make their trials visible to a larger, targeted audience. Users can search by type of cancer (for example, pleural mesothelioma, peritoneal mesothelioma, tunica vaginalis mesothelioma, or pericardial mesothelioma) and then narrow results by geographic location, from state-level searches down to city or zip-code proximity options. The combination of disease specificity and location-based searching is meant to cut through the noise of broader clinical-trial registries and accelerate connections between patients and trials that are realistically accessible.

Once a patient or caregiver builds a shortlist of promising trials, the site emphasizes the practical next step: patients are encouraged to take the list to their treating physicians to discuss feasibility and eligibility. The goal is to put the patient in the driver’s seat but with a solid reminder that treatment should be a collaboration between patient/family and physician. Having a curated list of clinical trials in hand at their appointment can help streamline the conversation and rapidly assess whether a trial’s inclusion criteria apply to that patient based on data from previous phases of that trial, the patient’s disease stage, previous treatment and response, and wellbeing.

The platform also invites doctors and researchers to submit their trials for inclusion.

While clinical trials are experimental and not yet proven treatments, in a rare cancer like mesothelioma with few available treatments with limited effectiveness, they are a way to try something different, especially when other things haven’t worked or stopped working. But that doesn’t mean that no data exists for these novel treatments. In fact, the opposite is often true. The new treatments tend to already have data in other cancers based and if the study is a Phase 3 clinical trial, then it also has data signals for mesothelioma specifically.

Clinical trials proceed in phases — from early, small safety studies (Phase I) to larger tests of effectiveness (Phase II and III) and post-approval follow-ups (Phase IV). For patients with mesothelioma, particularly those with advanced or treatment-resistant disease, clinical trials can provide access to the latest therapies before they are widely available, including targeted therapies, immunotherapies, and novel combination strategies. Participation can offer potential clinical benefits such as tumor shrinkage or prolonged disease control; at the same time, trials also carry risks and may not be effective for every participant. Importantly, clinical trials generate the evidence that advances cancer treatment for all patients in the future.

The site’s mesothelioma-only focus is the feature that sets it apart. Whereas registries that catalog trials across all cancers can be comprehensive, they are not always user-friendly for users without a medical background. By concentrating on one disease group, the search tool can present deeper, more relevant filtering options and educational material tailored to mesothelioma patients’ unique needs.

For investigators and research sites, the platform also offers visibility benefits. Submitting a trial to the search tool increases the chance that eligible patients and referring physicians who are specifically searching for mesothelioma options will find the trial. That improved visibility can accelerate enrollment, reduce screening times, and help trials reach target accrual sooner.

As clinical research continues to expand and treatments for mesothelioma evolve rapidly, tools that connect patients and clinicians to appropriate studies are increasingly valuable. This mesothelioma-dedicated, free, searchable database with disease-type and location filters and a direct submission process for investigators aims to be a practical bridge between the clinical-research community and the people who may benefit from participation. Patients and clinicians interested in exploring the new search tool can visit mesotheliomahelp.org to begin searching, learn how to submit trials, and find resources to guide conversations with treating physicians about clinical-trial options.